Market open
Inotiv/NOTV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inotiv
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Ticker
NOTV
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
2,005
Website
Inotiv Metrics
BasicAdvanced
$45M
Market cap
-
P/E ratio
-$3.85
EPS
3.35
Beta
-
Dividend rate
Price and volume
Market cap
$45M
Beta
3.35
52-week high
$11.42
52-week low
$1.23
Average daily volume
162K
Financial strength
Current ratio
0.308
Quick ratio
0.167
Long term debt to equity
21.853
Total debt to equity
236.007
Interest coverage (TTM)
-0.83%
Management effectiveness
Return on assets (TTM)
-2.92%
Return on equity (TTM)
-43.15%
Valuation
Price to revenue (TTM)
0.088
Price to book
0.25
Price to tangible book (TTM)
-0.23
Price to free cash flow (TTM)
-5.001
Growth
Revenue change (TTM)
-13.93%
Earnings per share change (TTM)
-70.91%
3-year revenue growth (CAGR)
88.09%
3-year earnings per share growth (CAGR)
448.40%
What the Analysts think about Inotiv
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inotiv stock.
Inotiv Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inotiv Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inotiv News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inotiv stock?
Inotiv (NOTV) has a market cap of $45M as of October 11, 2024.
What is the P/E ratio for Inotiv stock?
The price to earnings (P/E) ratio for Inotiv (NOTV) stock is 0 as of October 11, 2024.
Does Inotiv stock pay dividends?
No, Inotiv (NOTV) stock does not pay dividends to its shareholders as of October 11, 2024.
When is the next Inotiv dividend payment date?
Inotiv (NOTV) stock does not pay dividends to its shareholders.
What is the beta indicator for Inotiv?
Inotiv (NOTV) has a beta rating of 3.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.